BioSpace News Archive

Amgen announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors.

BC Platforms announced that it has formed a collaboration with Debiopharm, a Swiss pharmaceutical company, to deliver a complete clinical and genomic data management solution to support its innovative oncology pipeline, including investigational product programs for Debio 0123, diagnostic molecular screening for Debio 1347 and clinical exploratory results for Debio 1143.

With more than 25 years experience in chemotherapeutic products and cancer vaccines, she will lead the ongoing phase I/II trial in NSCLC

New role builds on growing interest in BioAscent’s integrated discovery services

Evanescent Acoustic Beam Moves Suspended Particles at Lower Cost & Energy Consumption Than Existing Propagative Surface Acoustic Wave (SAW) Systems

Soricimed Biopharma Inc. announced that it has entered into a strategic alliance with Image Analysis Group, a UK-based company with unique expertise in medical imaging and artificial intelligence-based image analytics, whereby the companies will join their efforts in the development of Soricimed’s lead anti-cancer drug candidate, SOR-C13, a first-in-class inhibitor of the TRPV6 calcium channel.

ADC Therapeutics SA announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common shares.

4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final close

PharmaMar (MSE:PHM) presented new data on lurbinectedin during the World Conference on Lung Cancer (WCLC), which is taking place from 7th to 10th September in Barcelona.

Emerald Lake Safety’s Dr. Christina Chow will be co-chairing a symposium on drug safety research in obese patients on Sept. 15 at the 2019 American College of Clinical Pharmacology (ACCP) meetings in Chicago, Illinois.